13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001590144
Total reported value
$37.0M
$37.0M
46 檔
142.4%
The Q2 2024 SEC filing reveals that Pura Vida Investments, LLC held a total portfolio value of $37.0M, covering 46 public equity positions.
During Q2 2024, Pura Vida Investments, LLC's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 8.61% | — | — | |
| 2 | ✓ | Establishment Labs Holdings In | Stock-Other | 6.62% | -6.73% | -12.07% | |
| 3 | GKOS | Glaukos CORP | Stock-Healthcare | 6.52% | — | +10.13% | |
| 4 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 6.06% | — | — | |
| 5 | MASI* | Masimo CORP | Stock-Other | 5.54% | — | — | |
| 6 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 5.32% | — | -21.41% | |
| 7 | NTRA | Natera Inc | Stock-Healthcare | 4.63% | -2.26% | -5.73% | |
| 8 | LIVN | LivaNova PLC | Stock-Other | 4.34% | — | +38.71% | |
| 9 | MSOS | Advisorshares Pure US Cann | ETF-Other | 3.65% | — | +35.69% | |
| 10 | QTRX | Quanterix CORP | Stock-Other | 3.42% | — | +8.87% | |
| 11 | ACWX | Ishares Msci Acwi Ex US ETF | ETF-Other | 3.19% | — | — | |
| 12 | XITK | Ss Spdr F Inno Tech ETF | ETF-Tech | 2.93% | — | — | |
| 13 | RMD | Resmed Inc | Stock-Healthcare | 2.91% | — | — | |
| 14 | IXP | Ishares Global Comm Services | ETF-Other | 2.57% | — | — | |
| 15 | INSP | Inspire Medical Systems Inc | Stock-Healthcare | 2.54% | — | +100.00% | |
| 16 | ICUI | Icu Medical Inc | Stock-Other | 2.20% | — | — | |
| 17 | CSTL | Castle Biosciences Inc | Stock-Other | 2.11% | — | — | |
| 18 | LUNG | Pulmonx CORP | Stock-Other | 2.06% | — | +9.89% | |
| 19 | GH | Guardant Health Inc | Stock-Healthcare | 1.83% | — | — | |
| 20 | STAA | Staar Surgical Co | Stock-Other | 1.81% | — | — | |
| 21 | ARKG | Ark Genomic Revolution ETF | ETF-Other | 1.71% | — | — | |
| 22 | COO | Cooper Cos Inc/the | Stock-Healthcare | 1.66% | — | — | |
| 23 | MDT | Medtronic plc | Stock-Healthcare | 1.49% | — | — | |
| 24 | ARKK | Ark Innovation ETF | ETF-Other | 1.39% | — | — | |
| 25 | ATEC | Alphatec Holdings Inc | Stock-Other | 1.32% | — | -37.82% | |
| 26 | BRKR | Bruker CORP | Stock-Healthcare | 1.31% | — | — | |
| 27 | DHR | Danaher CORP | Stock-Healthcare | 1.19% | — | — | |
| 28 | CUTREUR | Cutera Inc | Stock-Other | 1.11% | — | +8.07% | |
| 29 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 1.03% | — | -4.71% | |
| 30 | BVS | Bioventus Inc - A | Stock-Other | 1.02% | — | — | |
| 31 | IMDX | Insight Molecular Diagnostic | Stock-Other | 0.92% | -13.15% | -5.46% | |
| 32 | ZIMV | Zimvie Inc | Stock-Other | 0.81% | — | -4.23% | |
| 33 | NSPR | Inspiremd Inc | Stock-Other | 0.71% | -4.09% | — | |
| 34 | SOLV | Solventum CORP | Stock-Healthcare | 0.70% | — | — | |
| 35 | STE | STERIS plc | Stock-Healthcare | 0.69% | — | — | |
| 36 | INMD | InMode Ltd. | Stock-Other | 0.69% | — | — | |
| 37 | PEN | Penumbra Inc | Stock-Healthcare | 0.68% | — | — | |
| 38 | MGX | Metagenomi Therapeutics Inc | Stock-Other | 0.66% | -1.53% | -41.33% | |
| 39 | ELAN | Elanco Animal Health Inc | Stock-Healthcare | 0.52% | — | -70.71% | |
| 40 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.49% | — | — | |
| 41 | TWST | Twist Bioscience CORP | Stock-Other | 0.31% | — | — | |
| 42 | NARIUSD | Inari Medical Inc | Stock-Other | 0.30% | — | — | |
| 43 | ENOV | Enovis CORP | Stock-Other | 0.23% | — | — | |
| 44 | WGS | Genedx Holdings CORP | Stock-Other | 0.17% | — | — | |
| 45 | TALKW | Hudson Executive Inv -cw25 | Stock-Other | 0.02% | — | -36.90% | |
| 46 | ✓ | Wm Technology Inc | Stock-Other | — | — | — |
According to official SEC Form 13F filings, Pura Vida Investments, LLC reported a total U.S. public equity portfolio value of $37.0M across 46 disclosed positions in Q2 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, ESTABLISHMENT LABS HOLDINGS IN, GKOS) accounted for 142.4% of total reported equity market value during Q2 2024.
During Q2 2024, Pura Vida Investments, LLC's top holdings by market value included SPY (8.6%)、ESTABLISHMENT LABS HOLDINGS IN (6.6%)、GKOS (6.5%). The largest single position, SPY, represented 8.6% of total portfolio value.
In Q2 2024, Pura Vida Investments, LLC made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.